News

TB R&D Weekly Update: Podcast Interview with Dr. Bernard Fourie

Dr. Bernard Fourie
Dr. Bernard Fourie

Listen to Bernard Fourie Podcast

Summary: The WGND had the opportunity to interview Dr. Bernard Fourie who is head of Medicine in Need-South Africa (MEND-SA). In addition, Dr. Fourie is an Extraordinary Professor of Medical Microbiology at the University of Pretoria, South Africa. In the interview, we discuss the ongoing projects at the Drug Research Laboratory at MEND-SA, a research and development center with the mission to developing and applying innovative approaches to the formulation and optimization of existing drugs for the treatment of tuberculosis.

Additional TB R&D News:

Realignment of the Office of Antimicrobial Products within the Office of New Drugs

30 Organizations Issue Recommendations For Congress, Administration And FDA To Find Innovative Ways To Spur A New Era Of Global Health Breakthroughs

How health R&D can boost development

Final child vaccinated in clinical trial of new TB vaccine

CD8 T-cell response may be associated with tuberculosis in children

More News
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023
The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...